News for December 2017

TxCell completes CAR-Treg manufacturi... 19 December 2017
image description

Process will transfer to CMO before start of first-in-man clinical trial....

Read more
Sickness data to help NHS cope with w... 19 December 2017
image description

Data will be used to study winter surges....

Read more
Clinical trial transparency achieves... 19 December 2017
image description

New study indicates that disclosure rate at 12 months has improved....

Read more
DePuy Synthes releases Continuous Com... 19 December 2017
image description

Implants help address challenges of foot and ankle procedures....

Read more
Investigational compound Cx601 receiv... 18 December 2017
image description

Opinion based on results from TiGenix’s Phase III ADMIRE-CD pivotal trial....

Read more
NICE recommends Imbruvica for MCL pat... 18 December 2017
image description

Disease is rare type of B cell non-Hodgkin lymphoma....

Read more
FDA accepts Tagrisso regulatory submi... 18 December 2017
image description

FDA grants lung cancer drug Priority Review status....

Read more
CRT & Celgene form drug discovery all... 18 December 2017
image description

Collaboration centred on the cellular process of assembling proteins....

Read more
Microbubbles could 'revolutionise' fu... 13 December 2017
image description

Thousands of the bubbles can fit on a grain of sand....

Read more
Janssen reports follow-up data on Imb... 12 December 2017
image description

Data were presented in an oral presentation at the 59th Annual ASH Meeting and Exposition....

Read more
Could build-up of urea in brain cause... 12 December 2017
image description

Findings build on earlier research published last year....

Read more
IMBRUVICA follow-up data suggest long... 11 December 2017

CLL is most common form of leukaemia in adults....

Read more
AMRA & Artialis partner for sarcopeni... 7 December 2017
image description

Companies aim to identify new, more specific biomarkers for musculoskeletal disorder....

Read more
Novartis reports positive Kisqali res... 7 December 2017
image description

Company shares data from Phase III MONALEESA-7 trial....

Read more
Toujeo meets key objective in head-to... 5 December 2017
image description

Toujeo is currently marketed in the U.S. and European Union....

Read more
iNNOVATE study meets primary endpoint 5 December 2017
image description

IMBRUVICA (ibrutinib) is a first-in-class Bruton's tyrosine kinase inhibitor....

Read more